3 minutes

Loblaw (TSX: L) 1Q19 Results: Comp Growth Strengthens in Retail

Primary Analyst: Coresight Research
Contributors
Primary Analyst: Coresight Research
Other Contributors:
John Mercer, Head of Global Research and Managing Director of Data-Driven Research
Company Earnings Update

Executive Summary

  • In 1Q19, ended March 23, Loblaw reported strengthening in same-store growth in both its food retail and drug retail segments.
  • Operating income and adjusted EBITA were impacted by the IFRS 16 accounting change. Adjusted EBITDA of was up 42%, or C$313 million, and comfortably exceeded expectations
  • Management maintained FY19 guidance for positive same-store sales and a stable gross margin in the retail segment.

Please Login to read the full report. Not a member? Register for a free user account.